Silence Therapeutics Plc (SLN)
13.30
-0.25
(-1.85%)
USD |
NASDAQ |
Sep 10, 16:00
13.30
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics Total Liabilities (Quarterly) : 67.94M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.94M |
| March 31, 2026 | 65.72M |
| December 31, 2025 | 69.14M |
| September 30, 2025 | 72.73M |
| June 30, 2025 | 71.08M |
| March 31, 2025 | 72.56M |
| September 30, 2024 | 100.42M |
| June 30, 2024 | 96.23M |
| March 31, 2024 | 89.03M |
| Date | Value |
|---|---|
| December 31, 2023 | 97.87M |
| September 30, 2023 | 95.13M |
| June 30, 2023 | 102.29M |
| March 31, 2023 | 96.13M |
| December 31, 2022 | 102.76M |
| September 30, 2022 | 100.36M |
| June 30, 2022 | 107.05M |
| March 31, 2022 | 109.01M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 6.062M |
| NuCana Plc | 7.330M |
| Autolus Therapeutics Plc | 418.39M |
| Compass Pathways Plc | 420.03M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.41M |
| Shareholders Equity (Quarterly) | 38.47M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 7.416 |
| Net Debt Paydown Yield | 0.00% |